REXAHN PHARMACEUTICALS INC
Q4 2016 13F Holders
CUSIP
761640101
Type
Equity
Class
COM
Num filings
31
Total reported value, excl. options
$3.20 M
Compare 2016 Q4 to
2018 Q3
2018 Q2
2018 Q1
2017 Q4
2017 Q3
2017 Q2
2017 Q1
2016 Q3
2016 Q2
2016 Q1
2015 Q4
2015 Q3
2015 Q2
2015 Q1
2014 Q4
2014 Q3
2014 Q2
2014 Q1
Manager
Report Date
Value ($000)
Shares
Option Type